Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220006713 220002580 1.66 65.8 null 2017-12-19 2017-12-19 FLAG + Idarubicin N N 220030858 FLAG + IDARUBICIN
220006714 220002580 0 136.3 Curative (C) null 2018-05-16 Nilotinib 2 N 220030858 NILOTINIB
220006715 220002581 null null Curative (C) 2017-10-05 2017-10-15 AML MyeChild 01 A Mitozantrone/Cytarabine 2 N 220030880 NOT MATCHED
220006716 220002581 1.78 85 Curative (C) 2014-06-03 2014-06-08 FLAG + Idarubicin N N 220030880 FLAG + IDARUBICIN
220006717 220002581 0 null Disease modification (D) null 2013-01-17 Nilotinib 02 N 220030880 NILOTINIB
220006718 220018854 1.63 80 Curative (C) 2016-12-08 2016-12-08 AML 19 TRIAL Y null 220030885 AML19 TRIAL
220006719 220018854 1.78 null Curative (C) 2015-07-30 2015-08-10 FLAG + Idarubicin N N 220030885 FLAG + IDARUBICIN
220006720 220002582 1.56 52.7 Curative (C) 2014-09-13 2014-09-13 AML MyeChild 01 Triple IT N N 220030887 NOT MATCHED
220006721 220011493 1.69 52.2 Curative (C) 2013-07-14 2013-07-14 AML 19 TRIAL 1 N 220030888 AML19 TRIAL
220006722 220002583 null 85 Curative (C) 2016-05-03 2016-05-04 AML 19 TRIAL + CYTARABINE + FLUDARABINE + IDARUBICIN + mylotarg Y N 220030890 NOT MATCHED
220006723 220002583 1.62 85 Curative (C) 2016-08-01 2016-08-01 AML 19 TRIAL 01 N 220030890 AML19 TRIAL
220006724 220002583 1.56 91.3 Curative (C) 2013-08-13 2013-08-13 AML 19 TRIAL 01 N 220030890 AML19 TRIAL
220006725 220002583 1.71 89 Curative (C) 2014-08-20 2014-08-20 AML 19 TRIAL Y N 220030890 AML19 TRIAL
220006726 220002584 1.53 75 Curative (C) 2015-12-12 2015-12-12 FLAG + Idarubicin 02 N 220030901 FLAG + IDARUBICIN
220006730 220002585 1.94 74.6 Curative (C) 2014-09-28 2014-09-29 AML Interim Guidelines FLAG-Ida 02 N 220030915 FLAG + IDARUBICIN
220006732 220011496 1.56 78 Curative (C) 2013-09-27 2013-10-05 AML 19 TRIAL 01 N 220030919 AML19 TRIAL
220006733 220002587 1.67 63 Adjuvant (A) 2014-08-28 2014-08-29 FLAG + Idarubicin N N 220030921 FLAG + IDARUBICIN
220006734 220002587 1.7 62.1 Curative (C) 2016-10-05 2016-10-05 AML 19 TRIAL 1 N 220030921 AML19 TRIAL
220006735 220002587 null null Curative (C) null 2017-09-18 Nilotinib N N 220030921 NILOTINIB
220006736 220002588 null 20.8 Curative (C) 2013-11-02 2013-11-02 null N N 220030929 NOT MATCHED
220006737 220011498 null 46.2 Curative (C) 2015-12-14 2015-12-23 AML MyeChild 01 IT Cyt N N 220030930 NOT MATCHED
220006738 220002589 null 111 Disease modification (D) 2014-04-11 2014-04-11 Nilotinib N N 220030931 NILOTINIB
220006739 220002589 1.76 73 Curative (C) 2017-05-19 2017-05-30 FLAG + Idarubicin Y N 220030931 FLAG + IDARUBICIN
220006740 220002590 1.9 80.7 Curative (C) 2017-06-14 2017-06-15 AML 19 TRIAL 1 null 220030939 AML19 TRIAL
220006741 220002591 0 64 Curative (C) 2016-04-26 2016-04-26 Nilotinib N N 220030940 NILOTINIB
220006742 220002591 1.59 53.9 Curative (C) 2016-03-05 2016-03-05 AML 19 TRIAL Y N 220030940 AML19 TRIAL
220006743 220002592 1.56 null null 2014-02-14 2014-02-17 AML Interim Guidelines FLAG-Ida 99 null 220030945 FLAG + IDARUBICIN
220006744 220002592 1.75 78.9 Curative (C) 2014-01-07 2014-01-07 AML 19 TRIAL 02 N 220030945 AML19 TRIAL
220006745 220016185 0 null Adjuvant (A) 2015-11-05 2015-11-16 Nilotinib N N 220030952 NILOTINIB
220006746 220016185 null null Disease modification (D) null 2014-02-13 Nilotinib N N 220030952 NILOTINIB
220006747 220016185 null 105.5 Curative (C) 2017-04-15 2017-04-18 AML 19 TRIAL 01 N 220030952 AML19 TRIAL
220006748 220016185 0 0 Disease modification (D) 2014-06-03 2014-06-03 Nilotinib N N 220030952 NILOTINIB
220006749 220002593 1.8 68.2 Curative (C) null 2016-10-20 AML 19 TRIAL N N 220030959 AML19 TRIAL
220006750 220002593 1.68 80.2 Curative (C) 2014-05-06 2014-05-12 AML 19 TRIAL 01 N 220030959 AML19 TRIAL
220006751 220002594 0 67.8 null 2016-05-05 2016-05-16 Nilotinib 02 N 220030961 NILOTINIB
220006752 220002595 1.53 81.9 Curative (C) null 2013-08-25 FLAG + Idarubicin 1 N 220030962 FLAG + IDARUBICIN
220006753 220002595 null 95 Curative (C) 2017-11-11 2017-11-12 AML 19 TRIAL Y N 220030962 AML19 TRIAL
220006754 220002596 null 66.2 Disease modification (D) 2014-04-15 2014-04-15 Nilotinib N N 220030966 NILOTINIB
220006755 220011504 null 76 Curative (C) 2013-09-26 2014-08-15 AML MyeChild 01 IT Cyt Y N 220030967 NOT MATCHED
220006756 220011504 1.7 82.8 Curative (C) 2013-08-24 2013-08-25 AML 19 TRIAL Y N 220030967 AML19 TRIAL
220006757 220002597 1.65 73 null 2016-08-08 2016-08-08 FLAG + Idarubicin N N 220030970 FLAG + IDARUBICIN
220006758 220002597 null 0 Curative (C) 2013-11-17 2013-11-18 Nilotinib N null 220030970 NILOTINIB
220006759 220002598 null null Curative (C) 2017-07-14 2017-07-14 FLAG + Idarubicin 02 N 220030973 FLAG + IDARUBICIN
220006760 220002598 1.62 76.7 Curative (C) 2016-01-27 2016-01-27 AML 19 TRIAL N N 220030973 AML19 TRIAL
220006761 220002599 null null Curative (C) 2015-04-18 2015-04-18 Nilotinib 02 N 220030977 NILOTINIB
220006762 220002599 1.63 103.4 Neo-adjuvant (N) 2017-10-06 2017-10-06 FLAG + Idarubicin N N 220030977 FLAG + IDARUBICIN
220006763 220002599 null 0 Curative (C) null 2014-03-28 Nilotinib 2 N 220030977 NILOTINIB
220006764 220002600 1.75 null Curative (C) 2013-04-25 2013-04-25 Nilotinib Y N 220030987 NILOTINIB
220006765 220002600 null null Curative (C) 2015-06-30 2015-07-02 AML Interim Guidelines FLA -Ida 2 N 220030987 NOT MATCHED
220006766 220002600 null 81 Curative (C) 2018-09-27 2018-09-27 Nilotinib N N 220030987 NILOTINIB